William Haseltine, PhD
Chair and President of ACCESS Health International, USA
In Dr. Haseltine’s career at the forefront of medical research and application, he has educated a generation of doctors at Harvard Medical School, designed the strategy to develop the first treatment for HIV/AIDS, is well known for his groundbreaking work on cancer, and led the team that pioneered the development of new drugs based on information from the human genome. His relentless focus on delivering world-changing results led TIME magazine to name him one of the "25 Most Influential Global Business Executives."
Today, as the Chair and President of ACCESS Health International and an internationally recognized expert on the COVID-19 pandemic, Dr. Haseltine is dedicated to ensuring that quantum advancements in medical technology translate to improved health outcomes around the world.
Dr. Haseltine has founded more than a dozen biotechnology companies, including Human Genome Sciences, Inc. Eight pharmaceutical products from companies he founded are currently approved by U.S. and international regulatory agencies. He is the author of more than two hundred peer reviewed manuscripts and eleven books, including two books on COVID: A Family Guide to Covid and A Covid Back to School Guide. His most recent book, My Lifelong Fight Against Disease: From Polio and AIDS to COVID-19, was published in October 2020. He is currently chair and president of the global health think tank ACCESS Health International.